T-group (topology)
393.1.1 GLA-domain
Ligands and drugs
200
Member domains
60
with ligand contacts (≤ 4 Å)
30.0% of members
39
with DrugDomain annotations
19.5% of members
8
with a DrugBank compound
4.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 393.1.1 belongs to X-group 393 GLA-domain, which has 7 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB09332 | — | — | 4 |
| DB00170 | — | Menadione | 2 |
| DB03095 | TMA | Tetramethylammonium | 2 |
| DB03847 | — | — | 2 |
| DB04136 | LPS | Lysophosphotidylserine | 2 |
| DB07376 | — | 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID) | 2 |
| DB12598 | — | Nafamostat | 2 |
| DB00006 | — | — | 1 |
| DB00278 | — | — | 1 |
| DB00464 | — | — | 1 |
| DB00569 | — | — | 1 |
| DB01593 | — | — | 1 |
| DB01725 | — | 2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide | 1 |
| DB01766 | — | Beta-(2-Naphthyl)-Alanine | 1 |
| DB02287 | — | 2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine | 1 |
| DB04898 | — | — | 1 |
| DB05713 | — | — | 1 |
| DB05714 | — | — | 1 |
| DB06406 | — | — | 1 |
| DB06635 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 46 |
| MGmetal | MAGNESIUM ION | 23 |
| CO2 | CARBON DIOXIDE | 1 |
| LPS | O-{HYDROXY[((2R)-2-HYDROXY-3-{[(1S)-1-HYDROXYPENTADECYL]OXY}PROPYL)OXY]PHOSPHORYL}-L-SERINE | 1 |
| RBmetal | RUBIDIUM ION | 1 |
| SRmetal | STRONTIUM ION | 1 |
| TMA | TETRAMETHYLAMMONIUM ION | 1 |